Loading patent…
AssigneeKorea University Research and Business Foundation
InventorsSang Taek JUNG, Ji Sun LEE, Bo Mi KIM
Estimating the term…
The present invention relates to a human antibody against a novel coronavirus and a variant thereof, or an immunologically active fragment of the human antibody. The human antibody against a novel coronavirus and a variant thereof, or an immunologically active fragment of the human antibody can effectively keep COVID-19 virus from infecting a host by binding with high affinity to an RBD region of a spike protein of COVID-19 virus or a variant thereof, may be utilized for preventing or treating COVID-19 virus infection by binding to a variety of all variants of COVID-19 virus with high affinity, and may be advantageously utilized in diagnosis and epidemiological surveys of highly infectious covid-19 virus by enabling rapid diagnosis (detection) of various types of COVID-19 virus.
An antibody specific to COVID-19 virus (SARS-COV-2) or a variant thereof, or an immunologically active fragment thereof.
A method of preparing an antibody specific to COVID-19 virus or a variant thereof or an immunologically active fragment thereof, the method comprising:
16-17. (canceled)
21-24. (canceled)
Dependencies are inferred from the claim text.